StonvexLoading…
StonvexStonvexStonvexCore line items from S's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 | Annual 2023 2023-01-31 |
|---|---|---|---|---|
Revenue | $1.00B | $821.46M | $621.15M | $422.18M |
Operating Income | $-321.31M | $-329.36M | $-378.42M | $-402.58M |
Net Income | $-450.74M | $-288.44M | $-338.69M | $-378.68M |
EPS (Diluted) | $-1.37 | $-0.92 | $-1.15 | $-1.36 |
Total Assets | $2.44B | $2.41B | $2.32B | $2.26B |
Total Liabilities | $1.00B | $737.38M | $727.36M | $602.21M |
Cash & Equivalents | $169.63M | $186.57M | $256.65M | $137.94M |
Free Cash Flow OCF − CapEx | $75.90M | $31.87M | $-69.68M | $-198.24M |
Shares Outstanding | 330.11M | 314.81M | 294.92M | 277.80M |